Based on these findings, it is reasonable to conclude that the reversal of NAFLD-related alterations by PGG and metformin in the HFD-induced mouse model is closely linked to their combined effect to restore GNMT expression in liver cells. This evidence concerns the gene GNMT and metabolic dysfunction-associated steatotic liver disease.